Saliva is effective in screening for CMV infection in newborns, says NIH-funded research – 3
Narrator: This is NIH Health Matters. I’m Joe Balintfy. Congenital cytomegalovirus or CMV is commonly passed from a mother to her newborn. Of the 20,000-30,000 infants who are born infected with CMV each year, about 10-15 percent are at risk for developing hearing loss. Dr. Bracie Watson a program officer at NIH explains why researchers decided to explore a new screening for CMV.
Watson: Our first paper came out last year, showed that using the dry blood spot was likely missing a significant number of babies with CMV. So we went on to develop a different test using saliva rather than blood.
Narrator: For more information, visit www.nidcd.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.